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Characterisation  of the  adsorption  of  biomolecules,  or a biocorona,  on  nanomaterials  has proliferated  in
the  past  10  years,  as protein  corona  studies  provide  molecular  level  insight  into  mechanisms  of cellular
recognition,  uptake,  and  toxicity  of  nanomaterials.  At the crossroads  of  two  rapidly  evolving  orthogonal
fields,  nanoscience  and  proteomics,  the  interdisciplinarity  of protein  corona  studies  creates  challenges
for experimental  design  and  reporting.  Here  we propose  a flexible  checklist  for experimental  design
and  reporting  guidelines  to outline  Minimum  Information  about  Nanomaterial  Biocorona  Experiments
(MINBE).  The  checklist  for experimental  design,  compiled  after review  of  reporting  within  the  protein
corona  literature,  provides  researchers  with  prompts  to ensure  best  practice  experimental  approaches
for  each  stage  of  the  workflow,  collated  from  the  nanoscience,  proteomics,  and  bioinformatics  fields.
Reporting  guidelines  are  also  assembled  from  established  sources,  integrated  to  span  the entire  workflow
and  extended  and  modified  to  aid interdisciplinary  researchers  in  the  most  challenging  stages  of the
workflow.  Where  appropriate,  de novo  guidelines  to  address  areas  specific  to  protein  corona  studies,
including  exposure  conditions  and  isolation  of  adsorbed  proteins,  were  written.  The  MINBE  guidelines
provide  protein  corona  researchers  with  a conduit  between  materials  science  techniques  and  proteomics.
Implementation  of these  guidelines  is  anticipated  to  catalyse  enhanced  quality,  impact,  and  extent  of
data mining  and  computational  modelling  of  protein  corona  composition  and  its  role  in  nanosafety  and
nanomedicine.  Furthermore,  high  quality  experimental  design  and  reporting  in  the  bio-nanosciences  will
enhance the  next phase  of  targeted  nanomedicines  and  sustainable  nanotechnologies.
©  2019  The  Authors.  Published  by  Elsevier  Ltd. This  is an  open  access  article  under  the CC  BY-NC-NDntroduction
Since the emergence of the term protein corona, interdisci-
linary teams have studied this spontaneously acquired coating of
roteins on the surface of engineered nanomaterials (ENMs) in liv-
ng systems [1]. This complex population of biomolecules includes
roteins [2] and lipids [3], and more recent research has explored
he presence of carbohydrates [4, 5] and other small molecules
metabolites) [6], which represent vital new areas for bio-nano
nteraction research, along with investigation of interaction of nat-
ral organic matter in environmental settings [7]. The corona not
nly creates a new biomolecular surface for the ENMs, but can
lso cause ENM transformations, including altering dissolution and
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agglomeration [8,9]. These newly acquired chemical and physical
properties, in turn, form a new biological identity for the ENM with
altered uptake and interactions with cellular receptors. Ultimately,
the corona modulates ENM immune response, toxicity, and distri-
bution [1,10]. Although computational modelling has the potential
to predict corona formation and organismal fate, the accuracy of
models depends heavily upon the quality, depth, and breadth of
collated databases of ENM corona compositions and cellular inter-
actions.
As interest in the ENM corona has increased, the field has estab-
lished a landscape of experimental approaches to characterize the
corona. Although other techniques can be used to monitor pat-
terns of change in the corona population, LC–MS/MS proteomic
approaches uniquely provide both identification and quantification
across the full population of proteins within the corona [8,11,12].
Initially, many studies isolated the corona with detergents and
ran them through gel electrophoresis. Specific bands were then
excised, digested and analysed by LC–MS/MS. This approach sig-
nificantly skews the results in favour of highly abundant proteins
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Fig. 1. The four phases of a corona characterization include: (1) ENM exposure to biofluids and ENM characterization (red bar), (2) isolation of absorbed biomolecules and
preparation for analysis (orange bar), (3) separation of biomolecules and spectroscopic characterization (green bar), and (4) informatic identification of the corona population
and  analysis.
Table 1
Checklist of questions to guide experimental design when characterizing the ENM biocorona.
Experimental design checklist for biocorona characterization
Phase 1: ENM exposure to biofluids and ENM characterization
• How can the biofluid be handled and stored to best reflect biological conditions?
•  What is the most relevant and appropriate dosage of ENMs in the chosen biofluid or hypothesis?
•  Does the study aim for analysis of the biocorona pre- or post-equilibrium? How was the timeline for equilibrium evaluated?
•  Are replicates and controls included? And, where possible, do plans include parallel processing of samples for proteomics and additional characterisation?
Phase  2: Isolation of absorbed biomolecules and preparation for analysis
•  Is the biocorona separation thorough enough to remove all unbound biomolecules?
•  Is the separation technique likely to alter the chemical structure of the biocorona, or the profile of biomolecules?
•  Will the biocorona clean-up steps affect the profile of your biomolecules?
•  What clean-up methods are likely to least alter the biocorona, e.g. through selective or pervasive protein loss?
Phase  3: Separation of biomolecules and spectroscopic characterization
•  What type of separation will be best for these samples (in gel, on-particle etc.)?
•  How can the protocol be modified to best maintain consistency across samples?
•  What instruments are best for these samples and quantification?
• What controls can be included to check for
Phase 4: Informatic identification of the biocorona population and analysis.
•  What informatics database will be used for identifying the biomolecules?
•  What kind of post-processing is required for quantification?
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t• What statistical analysis of the dataset can be used to assess data quality?
•  How will the full dataset of biomolecules and their characteristics be organized
hose concentration in the gel was sufficient to lead to visible
taining, such that the resulting corona analysis may  miss multiple
ow abundance / low staining efficiency proteins that could play
mportant biological roles. Thus, most recent corona characteriza-
ions use in-solution/on-particle digests for the characterisation of
he entire corona, with the addition of a surfactant such as Rapigest
FTM to prevent protein and peptide re-adsorption [8,11,13,14]. The
ypical four phase workflow for protein corona characterisation
Fig. 1 and Table 1) is highly interdisciplinary and requires exper-
ise in ENM characterization, mass spectroscopy, and informatics.
his array of specialisms introduces challenges to study design and
eporting. Commonly, nanoscientists have extensive knowledge
f materials characterization, but lack the background to explore
nformatics relevant to MS  proteomics whereas the reverse is true
or proteomicists. Guidance to provide depth of knowledge in these
isparate techniques could help researchers ensure sound experi-
ental design and reporting.
Recent scrutiny of the preproducibility (a term introduced to
escribe whether a study has been reported in sufficient detail
or others to undertake it) of scientific literature raises concerns
bout reporting adequate information for independent verifica-
ion of results and reviewing methodological soundness [15]. The
nterdisciplinarity of nano-bio studies further complicates prepro-
ucibility, as well as experimental design and data clarity. Recently,
he Minimum Information Reporting in Bio–Nano Experimental
iterature (MIRIBEL) guidelines were published to improve data
eusability, quantification, practicality, and quality in aspects of
NM and biologics characterisation in bio-nano interface studies
16]. These guidelines form an excellent basis for experiments up
o the moment of forming a corona. Here, MIRIBEL is extended to
ncompass corona characterisation by creating a conduit between
he fields of ENMs research and biological mass spectrometry.ysed, and presented?
The reporting guidelines presented are already established in the
individual fields but are integrated here and modified for corona
studies. The integrated guidelines, with summaries of their sci-
entific underpinnings, and the corona workflow and reporting
checklist, have been developed to enhance interoperability, pre-
producibility as the requisite to reproducibility, and utility of
corona characterizations. If implemented, the MINBE guidelines
will ease comparisons across datasets and enable predictive mod-
elling of corona formation and ENM impact. When applied, this will
accelerate innovation of targeted bioactive ENMs and sustainable
nanotechnologies.
Lessons learned for protein corona characterization
Despite publication of a suggested protocol for profiling of pro-
tein coronas roughly five years ago, [12] the field has yet to adopt
a best practice approach. In part, this is due to the broad range of
research questions, which demand variations in the protocol for
analysis. For example, ENMs extracted from blood plasma should
not be prepared and analysed with the same approach as ENMs
isolated from fish guts. It also stems from the enormous variability
in ENM characteristics, especially density, which makes it impos-
sible to provide an exact specification for centrifugation time and
speed to optimise the pelleting of the ENM with their associated
proteins. Yet, ten years after coining the term protein corona, the
field has reached a certain maturity. As corona specific characteri-
zation methods coalesce, the loose guidelines presented in Table 1,
developed from the analysis of literature reporting of corona stud-
ies presented briefly below, can aid experimental reproducibility
and provide reviewers with a guide for providing feedback on sub-
mitted studies.
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Table  2
Reporting standards for corona characterization. Colours within the subheadings correspond to those in the experimental steps outlined in Fig. 1 [25].
M /z: m
c
y
o
fl
rS:  Mass spectrometer, LC: Liquid Chromatography, ESI: Electrospray Ionisation, m
To assess the current state of reporting, we reviewed the most
ited protein corona papers using LC–MS/MS from the last few
ears. Although ENM exposure methods and characterization were
ften clearly defined and well reported, later stages in the work-
ow (shown in Fig. 1) were less clearly described. Key reporting
ecommendations based on gap analysis include:ass to charge ratio, AGC: Automatic Gain Control.
• Demonstrate reproducibility (workflow phases 1–4): A hallmark
of reproducibility is replication. Yet, authors often overlook inclu-
sion of a statement on replicates, technical or biological. Similarly,
few articles discussed quality control (QC) and evaluation of data
quality. By incorporating QC samples such as a stock tryptic digest
of HeLa cells or of universal protein standards, LC–MS/MS per-
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formance can be monitored over batches to assess instrument
sensitivity and consistency [17,18]. It is also vital to incorporate
both positive and negative controls into the experimental set up.
Negative controls would follow the entire workflow with incuba-
tion of the ENM in pure water to assess sources of contamination
and any existing protein present. A positive control represents the
workflow without the ENMs and is thus a digest of the biological
matrix.
Streamline purification methods (workflow phase 2): Protein
precipitation methods can alter the protein profile dramatically.
For example, a common solvent (trichloroacetic acid in acetone)
precipitation method in corona preparations selectively elimi-
nates human serum albumin from blood plasma [19], a protein
that is normally present in high concentrations [20]. Instead, we
recommend direct digestion of proteins on the ENM to minimize
steps where sample can be altered or lost – a protocol for this is
included in Faserl et al. [14].
Pay attention to quality and efficiency of separation and
detection (workflow phase 3): The quality and efficiency of
the separation and detection are critical for reliable iden-
tification and quantification of protein content of the ENM
corona. Because label-free quantification is predominant to
date, researchers must pay attention to difficulties in sample to
sample reproducibility for precursor selection and the daughter
ion intensities used for this quantification. If protein intensity is
reported, as opposed to fold changes or ratios between samples,
it is important to state how the label free quantification was
performed, which includes the number of peptides used to
quantify the protein and if it is the average intensity or summed
intensity of these peptides that is reported.
Take care with informatics (workflow phase 4): Often over-
looked, informatics methods are as essential as wet-lab details to
further reproducibility and confidence in protein identification
and quantification. Rarely were details such as false discovery
rates parameters for protein identification reported, yet, these
specifics are essential for accuracy and confidence in protein
identification and quantification.
These inconsistencies suggest that the field could benefit from
 broad checklist for experimental design in addition to reporting
uidelines. This checklist, shown in Table 1, will help researchers
o address important considerations at each step of the workflow
efore stepping into the lab.
inimum information about nanomaterial corona
xperiments (MINBE) reporting guidelines
Once a well-planned corona experiment has been carried out,
he preproducibility of the work depends upon the quality of
eporting. Precedent for reporting guidelines is well-established
n the biosciences and includes over forty standards for various
xperimental approaches [MIBBI] [21]. Implementation of stan-
ards provides the platform for increased quality of reporting
ithout disproportionate increase in cost, requiring only a marginal
mount of additional time from users. Aligned with previous mini-
um  information reporting guidelines for proteomics experiments
MIAPE] [22], proteomics analysis with LC–MS/MS (MIAPE-MS)
23], and proteomics data reporting [MIAPE-MSI] [24], we aimed to
alance the importance of detail in reporting with a flexibility that
llows for growth in new experimental analyses, techniques, and
nstrumentation. The MINBE reporting guidelines for ENM corona
tudies are presented in Table 2.day 28 (2019) 100758
Outlook
MINBE aims to provide clarity of experimental design and opti-
mal  reporting guidelines to characterize the composition ENM
protein coronas. To encourage reuse by researchers, granting
agencies, and publishers, the experimental checklist and report-
ing guidelines are available via a publicly accessible repository
<https://doi.org/10.17605/OSF.IO/3JB47>. Thus far, the field has
coalesced upon LC–MS/MS approaches for protein identification
and quantification. As the interdisciplinary, rapidly growing field
is constantly evolving, we also encourage edits and updates.
Careful molecular level characterization of the biological surface
of ENMs promises more accurate models of cellular and organismal
responses to ENM at the systems level. With compilation of strong
biocorona datasets, computational approaches can model individ-
ual biomolecules binding to ENMs [1,26], or predict a population
of biomolecules within a corona [27]. Importantly, computational
tools have predictive power across an array of samples and condi-
tions, saving experimental time and funds. The utility of biocorona
characterization extends across size-scales, from molecular level
insights to cellular, organismal, and systems level predictions of
ENM fate, transport, and toxicity [1,26,28,29]. Multivariate [2]
and machine learning models [27,30] can mine protein corona
databases and improve downstream modelling of ENM bioac-
tivity including cellular attachment, uptake, and response. Thus
far, corona modelling typically uses data collected in-house. Solid
experimental design and clear, detailed reporting, will facilitate col-
lation and mining of published datasets, enabling development of
improved quantitative and qualitative structure activity relation-
ship (QSAR) and artificial intelligence models.
With strong datasets and coordinated modelling, nanomedicine
and sustainable nanotechnologies can expand. Nanomedicine will
see increased selectivity for nano-based drug targeting, more
adaptable diagnostics devices, and decreased clinical translation
timescales. Enhanced personalisation of nanomedicines may be
achievable by comparing coronas across age, gender, health sta-
tus, and disease stages. Environmental applications may  benefit
the most, because full experimental characterization is near impos-
sible under the broad diversity of conditions, biomolecules, and
organisms in the environment. Biocorona datasets and modelling
can increase accuracy of ecotoxicity, food chain interactions, and
ENM transport predictions. With strong experimental design, clear
reporting, and cross-study modelling in the second decade of bio-
corona studies, we anticipate catalysis of the design of smart,
sustainable ENMs with maximized efficacy.
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